AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

6F1C M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Sinsan Pharmaceuticals

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview 6F1C M 50mg/500mg Tablet

This dual-action 50mg/500mg tablet effectively manages elevated blood glucose in type 2 diabetes patients. By controlling blood sugar, it mitigates severe diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risks. This medication may be used independently or in conjunction with other anti-diabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, blood glucose readings, and existing medications. Consuming it with meals minimizes gastrointestinal discomfort. Consistent daily administration at the same time maximizes efficacy; discontinue only under physician guidance. Adherence to your prescribed diet and exercise regimen is crucial for successful diabetes management. Lifestyle choices are key to diabetes control. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylureas; learn to identify and manage hypoglycemic episodes. This medication isn't suitable for all individuals. Inform your doctor of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption before starting treatment. Pregnant or lactating individuals require medical consultation prior to use. Drug interactions are possible; disclose all medications to your physician to ensure safety. Alcohol consumption should be minimized due to its potential to lower blood sugar. Your physician will monitor kidney function and blood glucose levels throughout your treatment.

Primary Ingredients of 6F1C M 50mg/500mg Tablet

No text provided to rephrase.

Uses of 6F1C M 50mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of 6F1C M 50mg/500mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 6F1C M 50mg/500mg tablet should be taken with a meal.

Common Side effects of 6F1C M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use 6F1C M 50mg/500mg Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the 6F1C M 50mg/500mg tablet with a meal.

How 6F1C M 50mg/500mg Tablet works:

6F1C M 50mg/500mg tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production by the pancreas, enhances insulin utilization, and lessens hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action optimizes blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside 6F1C M 50mg/500mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of 6F1C M 50mg/500mg tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of 6F1C M 50mg/500mg tablets while breastfeeding is likely inadvisable. Preliminary evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use the 50mg/500mg 6F1C M tablet cautiously, potentially requiring dosage modification. Consult your physician for guidance. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

Use of 6F1C M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Physician consultation is recommended.

What if you forget to take 6F1C M 50mg/500mg Tablet :

Should you forget to take your 6F1C M 50mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About 6F1C M 50mg/500mg Tablet

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Management

FAQs on 6F1C M 50mg/500mg Tablet

6F1C M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of 6F1C M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
6F1C M 50mg/500mg Tablets may cause common side effects including hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are possible. Prolonged use may also result in vitamin B12 deficiency.
Patients with allergies to 6F1C M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol with 6F1C M 50mg/500mg tablets is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Metformin (such as in 6F1C M 50mg/500mg Tablet) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA). This rare side effect necessitates avoiding metformin in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
6F1C M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
6F1C M 50mg/500mg Tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may also result in vitamin B12 deficiency.
Patients with allergies to any 6F1C M 50mg/500mg Tablet component or excipient, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and 6F1C M 50mg/500mg tablets is unsafe due to the increased risk of lactic acidosis.
Metformin (like in 6F1C M 50mg/500mg Tablet) can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA). This rare side effect is why metformin is avoided in people with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of 6F1C M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia (balance difficulties). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
6F1C M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
6F1C M 50mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to 6F1C M 50mg/500mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and 6F1C M 50mg/500mg tablets is unsafe due to an increased risk of lactic acidosis.
Metformin (like in the 6F1C M 50mg/500mg Tablet) can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of 6F1C M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
6F1C M 50mg/500mg Tablet
192
MRP 223
13% off